Speakers

Katie Aron

Director of Process Development

Obsidian Therapeutics

Sandhya Buchanan

VP Manufacturing & Quality

Arovella Therapeutics

Jenessa Smith

Director Process Development

ArsenalBio

Nick Timmins

CDO

Artisan Biotechnologies

Panos Chrysanthopoulos

Senior Director Process & Analytical Development

Artisan Biotechnologies

Patrick Bedford

VP Regulatory Strategy

Artisan Biotechnologies

Mark Lalli

Associate Director, Process Development

Be Biopharma

Pamela Wright

Executive Director, CAR-T Manufacturing Operations

Bristol Myers Squibb

Justin Skoble

VP, Technical Operations

Caribou Biosciences

Chris Deborde

Process Development Engineer

Century Therapeutics

Jose Vidal

COO

CytoImmune Therapeutics

Gregory Fiore

CEO

Exacis Biotherapeutics

Pooja Mehta

Senior Scientist

Immatics Biotechnologies

Forum Bhatt

Director CMC Strategy & Global Operations

Kite: A Gilead Company

Melissa DeFrancesco

Director Process Development

Lyell Immunopharma

Shyam Subramanian

CTO

Obsidian Therapeutics

James Bolling

Senior Director, Cell Therapy Process Development

Precision BioSciences

Marty Giedlin

VP Head of Technical Operations

Senti Bio

Kanika Chawla

VP Process Sciences

Syncopation Life Sciences

Amy Shaw

Associate Director Process Development Cell Therapies

Takeda

Danielle Hayes

Associate Director Bioprocess Engineering

Triumvira Immunologics

Luisa Davies

Senior Scientist, Manufacturing Technologies

Takeda

Nathan Moor

Associate Director, Engineering & Automation

Takeda